Alphatec (NASDAQ:ATEC – Get Free Report) and OrthoPediatrics (NASDAQ:KIDS – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations.
Volatility & Risk
Alphatec has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500.
Insider and Institutional Ownership
66.3% of Alphatec shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 32.5% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Alphatec and OrthoPediatrics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alphatec | -10.35% | -6,752.24% | -9.77% |
| OrthoPediatrics | -12.83% | -8.10% | -5.46% |
Analyst Recommendations
This is a summary of current ratings and target prices for Alphatec and OrthoPediatrics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alphatec | 1 | 2 | 11 | 0 | 2.71 |
| OrthoPediatrics | 1 | 1 | 7 | 0 | 2.67 |
Alphatec presently has a consensus target price of $15.63, suggesting a potential upside of 119.72%. OrthoPediatrics has a consensus target price of $30.75, suggesting a potential downside of 7.10%. Given Alphatec’s stronger consensus rating and higher probable upside, equities analysts clearly believe Alphatec is more favorable than OrthoPediatrics.
Valuation & Earnings
This table compares Alphatec and OrthoPediatrics”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alphatec | $839.72 million | 1.31 | -$143.36 million | ($0.55) | -12.94 |
| OrthoPediatrics | $236.35 million | 3.66 | -$39.65 million | ($1.43) | -23.15 |
OrthoPediatrics has lower revenue, but higher earnings than Alphatec. OrthoPediatrics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.
About Alphatec
Alphatec Holdings, Inc. is a medical technology company focused on developing and marketing products for spine surgery. Its offerings are intended to support the surgical treatment of spinal disorders and include implants, biologics, instruments and access systems, along with technologies designed to assist surgeons during procedures. The company’s product portfolio includes solutions for several surgical approaches and stages of spine care, including systems for planning, accessing and instrumenting the spine.
About OrthoPediatrics
OrthoPediatrics Corp. develops and markets orthopedic implants and instruments designed specifically for children and adolescents. Its products support surgeons treating a range of pediatric conditions, including fractures, spinal deformities, limb-length differences and other orthopedic disorders. The company’s portfolio includes systems for trauma and deformity correction, scoliosis treatment, limb lengthening and external fixation, as well as specialized surgical instruments. It also provides related education and support for pediatric orthopedic surgeons and care teams.
Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.
